

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | valine metabolic process (GO:0006573) | 5.71720994 |
| 2 | regulation of gene silencing by RNA (GO:0060966) | 5.64552269 |
| 3 | regulation of posttranscriptional gene silencing (GO:0060147) | 5.64552269 |
| 4 | regulation of gene silencing by miRNA (GO:0060964) | 5.64552269 |
| 5 | biotin metabolic process (GO:0006768) | 5.59949558 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.29606426 |
| 7 | L-phenylalanine catabolic process (GO:0006559) | 5.29606426 |
| 8 | alpha-linolenic acid metabolic process (GO:0036109) | 5.24925909 |
| 9 | regulation of sequestering of triglyceride (GO:0010889) | 5.17058021 |
| 10 | primary alcohol catabolic process (GO:0034310) | 5.16399512 |
| 11 | axonemal dynein complex assembly (GO:0070286) | 5.07789454 |
| 12 | L-phenylalanine metabolic process (GO:0006558) | 5.07411989 |
| 13 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.07411989 |
| 14 | fatty acid beta-oxidation (GO:0006635) | 5.03577386 |
| 15 | fatty acid transmembrane transport (GO:1902001) | 4.95362262 |
| 16 | sulfur amino acid catabolic process (GO:0000098) | 4.93334812 |
| 17 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.91185293 |
| 18 | low-density lipoprotein particle clearance (GO:0034383) | 4.87248298 |
| 19 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.84947509 |
| 20 | lysine catabolic process (GO:0006554) | 4.83796035 |
| 21 | lysine metabolic process (GO:0006553) | 4.83796035 |
| 22 | L-serine metabolic process (GO:0006563) | 4.80858282 |
| 23 | aromatic amino acid family catabolic process (GO:0009074) | 4.78845526 |
| 24 | cysteine metabolic process (GO:0006534) | 4.71310888 |
| 25 | acetyl-CoA metabolic process (GO:0006084) | 4.70791543 |
| 26 | fatty acid oxidation (GO:0019395) | 4.70280584 |
| 27 | carnitine shuttle (GO:0006853) | 4.63663816 |
| 28 | lipid oxidation (GO:0034440) | 4.62296658 |
| 29 | cellular glucuronidation (GO:0052695) | 4.59846961 |
| 30 | branched-chain amino acid metabolic process (GO:0009081) | 4.52505781 |
| 31 | complement activation, alternative pathway (GO:0006957) | 4.49996648 |
| 32 | fatty acid catabolic process (GO:0009062) | 4.49291611 |
| 33 | amino-acid betaine metabolic process (GO:0006577) | 4.48459737 |
| 34 | regulation of triglyceride catabolic process (GO:0010896) | 4.48191925 |
| 35 | branched-chain amino acid catabolic process (GO:0009083) | 4.47339419 |
| 36 | regulation of cell fate specification (GO:0042659) | 4.46259028 |
| 37 | short-chain fatty acid metabolic process (GO:0046459) | 4.44961006 |
| 38 | triglyceride catabolic process (GO:0019433) | 4.44322326 |
| 39 | uronic acid metabolic process (GO:0006063) | 4.43846875 |
| 40 | glucuronate metabolic process (GO:0019585) | 4.43846875 |
| 41 | exogenous drug catabolic process (GO:0042738) | 4.41631553 |
| 42 | indole-containing compound catabolic process (GO:0042436) | 4.41537809 |
| 43 | indolalkylamine catabolic process (GO:0046218) | 4.41537809 |
| 44 | tryptophan catabolic process (GO:0006569) | 4.41537809 |
| 45 | positive regulation of fatty acid oxidation (GO:0046321) | 4.37530650 |
| 46 | glycine metabolic process (GO:0006544) | 4.35818004 |
| 47 | serine family amino acid catabolic process (GO:0009071) | 4.27392431 |
| 48 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.26128350 |
| 49 | neutral lipid catabolic process (GO:0046461) | 4.25409626 |
| 50 | acylglycerol catabolic process (GO:0046464) | 4.25409626 |
| 51 | homocysteine metabolic process (GO:0050667) | 4.22645433 |
| 52 | serine family amino acid biosynthetic process (GO:0009070) | 4.21602006 |
| 53 | glyoxylate metabolic process (GO:0046487) | 4.20250801 |
| 54 | tryptophan metabolic process (GO:0006568) | 4.18861509 |
| 55 | urea cycle (GO:0000050) | 4.10899383 |
| 56 | urea metabolic process (GO:0019627) | 4.10899383 |
| 57 | bile acid biosynthetic process (GO:0006699) | 4.09909559 |
| 58 | acylglycerol homeostasis (GO:0055090) | 4.08760490 |
| 59 | triglyceride homeostasis (GO:0070328) | 4.08760490 |
| 60 | kynurenine metabolic process (GO:0070189) | 4.07818872 |
| 61 | monocarboxylic acid catabolic process (GO:0072329) | 4.07386968 |
| 62 | carnitine transport (GO:0015879) | 4.04000552 |
| 63 | amino-acid betaine transport (GO:0015838) | 4.04000552 |
| 64 | 2-oxoglutarate metabolic process (GO:0006103) | 4.03965315 |
| 65 | positive regulation of lipid catabolic process (GO:0050996) | 4.01081532 |
| 66 | ethanol metabolic process (GO:0006067) | 3.96024731 |
| 67 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.95752040 |
| 68 | plasma lipoprotein particle clearance (GO:0034381) | 3.93221356 |
| 69 | carnitine transmembrane transport (GO:1902603) | 3.92938235 |
| 70 | ethanol oxidation (GO:0006069) | 3.91444773 |
| 71 | establishment of integrated proviral latency (GO:0075713) | 3.88117208 |
| 72 | protein complex localization (GO:0031503) | 3.87558962 |
| 73 | carnitine metabolic process (GO:0009437) | 3.87213136 |
| 74 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.86834315 |
| 75 | quaternary ammonium group transport (GO:0015697) | 3.79395772 |
| 76 | brown fat cell differentiation (GO:0050873) | 3.79216989 |
| 77 | nitrogen cycle metabolic process (GO:0071941) | 3.78713125 |
| 78 | alpha-amino acid catabolic process (GO:1901606) | 3.77693649 |
| 79 | regulation of fatty acid oxidation (GO:0046320) | 3.77262479 |
| 80 | regulation of protein activation cascade (GO:2000257) | 3.76347424 |
| 81 | gap junction assembly (GO:0016264) | 3.75376342 |
| 82 | establishment of apical/basal cell polarity (GO:0035089) | 3.74476762 |
| 83 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 3.71108514 |
| 84 | response to nitrosative stress (GO:0051409) | 3.71043415 |
| 85 | bile acid metabolic process (GO:0008206) | 3.70972488 |
| 86 | cellular amino acid catabolic process (GO:0009063) | 3.69522337 |
| 87 | carboxylic acid catabolic process (GO:0046395) | 3.68432995 |
| 88 | organic acid catabolic process (GO:0016054) | 3.68432995 |
| 89 | drug catabolic process (GO:0042737) | 3.67730987 |
| 90 | serine family amino acid metabolic process (GO:0009069) | 3.67316958 |
| 91 | paraxial mesoderm development (GO:0048339) | 3.67015326 |
| 92 | tricarboxylic acid metabolic process (GO:0072350) | 3.65384507 |
| 93 | regulation of complement activation (GO:0030449) | 3.63213814 |
| 94 | drug transmembrane transport (GO:0006855) | 3.58453432 |
| 95 | acyl-CoA biosynthetic process (GO:0071616) | 3.57404553 |
| 96 | thioester biosynthetic process (GO:0035384) | 3.57404553 |
| 97 | fatty acid homeostasis (GO:0055089) | 3.55513311 |
| 98 | triglyceride biosynthetic process (GO:0019432) | 3.52853594 |
| 99 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.52793829 |
| 100 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.51049764 |
| 101 | protein carboxylation (GO:0018214) | 3.50225812 |
| 102 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.50225812 |
| 103 | neutral lipid biosynthetic process (GO:0046460) | 3.50102858 |
| 104 | acylglycerol biosynthetic process (GO:0046463) | 3.50102858 |
| 105 | negative regulation of lipase activity (GO:0060192) | 3.49526459 |
| 106 | urate metabolic process (GO:0046415) | 3.47795532 |
| 107 | triglyceride metabolic process (GO:0006641) | 3.46442628 |
| 108 | aromatic amino acid family metabolic process (GO:0009072) | 3.44648323 |
| 109 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.42654899 |
| 110 | pre-miRNA processing (GO:0031054) | 3.42195100 |
| 111 | white fat cell differentiation (GO:0050872) | 3.39953372 |
| 112 | cellular ketone body metabolic process (GO:0046950) | 3.39300575 |
| 113 | positive regulation of catenin import into nucleus (GO:0035413) | 3.38155249 |
| 114 | cellular modified amino acid catabolic process (GO:0042219) | 3.37616387 |
| 115 | tyrosine metabolic process (GO:0006570) | 3.37582934 |
| 116 | regulation of triglyceride metabolic process (GO:0090207) | 3.35699908 |
| 117 | nodal signaling pathway (GO:0038092) | 3.35266754 |
| 118 | regulation of cholesterol storage (GO:0010885) | 3.34145530 |
| 119 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.33156308 |
| 120 | cilium movement (GO:0003341) | 3.33075955 |
| 121 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.32363937 |
| 122 | phospholipid homeostasis (GO:0055091) | 3.30515048 |
| 123 | heterochromatin organization (GO:0070828) | 3.30456155 |
| 124 | acylglycerol metabolic process (GO:0006639) | 3.28889362 |
| 125 | regulation of stem cell maintenance (GO:2000036) | 3.28669019 |
| 126 | cellular protein complex localization (GO:0034629) | 3.28195812 |
| 127 | regulation of cholesterol metabolic process (GO:0090181) | 3.27341120 |
| 128 | aspartate family amino acid catabolic process (GO:0009068) | 3.26851925 |
| 129 | acyl-CoA metabolic process (GO:0006637) | 3.26590583 |
| 130 | thioester metabolic process (GO:0035383) | 3.26590583 |
| 131 | high-density lipoprotein particle remodeling (GO:0034375) | 3.26365633 |
| 132 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 3.25911593 |
| 133 | neutral lipid metabolic process (GO:0006638) | 3.23499022 |
| 134 | vitamin transmembrane transport (GO:0035461) | 3.23029233 |
| 135 | glomerular epithelial cell development (GO:0072310) | 3.16311276 |
| 136 | protein localization to kinetochore (GO:0034501) | 3.13238525 |
| 137 | regulation of fibrinolysis (GO:0051917) | 3.05808781 |
| 138 | anterior/posterior axis specification, embryo (GO:0008595) | 3.05539912 |
| 139 | regulation of cell fate commitment (GO:0010453) | 2.97719785 |
| 140 | negative regulation of cell fate specification (GO:0009996) | 2.97422334 |
| 141 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.96983699 |
| 142 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.92809376 |
| 143 | regulation of helicase activity (GO:0051095) | 2.91548992 |
| 144 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.91369646 |
| 145 | negative regulation of cell fate commitment (GO:0010454) | 2.90787359 |
| 146 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 2.88442475 |
| 147 | establishment of monopolar cell polarity (GO:0061162) | 2.88442475 |
| 148 | lung-associated mesenchyme development (GO:0060484) | 2.86647204 |
| 149 | negative regulation of fibrinolysis (GO:0051918) | 2.83563306 |
| 150 | epoxygenase P450 pathway (GO:0019373) | 2.82721417 |
| 151 | motile cilium assembly (GO:0044458) | 2.78896718 |
| 152 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.78869654 |
| 153 | polyketide metabolic process (GO:0030638) | 2.78663896 |
| 154 | doxorubicin metabolic process (GO:0044598) | 2.78663896 |
| 155 | daunorubicin metabolic process (GO:0044597) | 2.78663896 |
| 156 | establishment of viral latency (GO:0019043) | 2.77681003 |
| 157 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.77128860 |
| 158 | primary alcohol metabolic process (GO:0034308) | 2.74868404 |
| 159 | epithelial cilium movement (GO:0003351) | 2.71655589 |
| 160 | chromatin remodeling at centromere (GO:0031055) | 2.71148455 |
| 161 | omega-hydroxylase P450 pathway (GO:0097267) | 2.68530222 |
| 162 | notochord development (GO:0030903) | 2.66720963 |
| 163 | mitotic metaphase plate congression (GO:0007080) | 2.65215442 |
| 164 | response to mercury ion (GO:0046689) | 2.60265489 |
| 165 | fibrinolysis (GO:0042730) | 2.59683850 |
| 166 | CENP-A containing nucleosome assembly (GO:0034080) | 2.57633165 |
| 167 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.56570264 |
| 168 | citrulline biosynthetic process (GO:0019240) | 2.54849003 |
| 169 | protein localization to chromosome, centromeric region (GO:0071459) | 2.53334547 |
| 170 | purine nucleobase biosynthetic process (GO:0009113) | 2.52894998 |
| 171 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.50558388 |
| 172 | regulation of gene silencing (GO:0060968) | 2.49756468 |
| 173 | NADPH regeneration (GO:0006740) | 2.49372627 |
| 174 | lateral sprouting from an epithelium (GO:0060601) | 2.47528923 |
| 175 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.47255817 |
| 176 | DNA replication checkpoint (GO:0000076) | 2.46164031 |
| 177 | negative regulation of gene silencing (GO:0060969) | 2.45251032 |
| 178 | negative regulation of androgen receptor signaling pathway (GO:0060766) | 2.44091389 |
| 179 | regulation of apoptotic cell clearance (GO:2000425) | 2.43977809 |
| 180 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.43597743 |
| 181 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.42344152 |
| 182 | negative regulation of sterol transport (GO:0032372) | 2.42208591 |
| 183 | negative regulation of cholesterol transport (GO:0032375) | 2.42208591 |
| 184 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 2.42091844 |
| 185 | negative regulation of telomerase activity (GO:0051974) | 2.41649715 |
| 186 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.41584144 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 8.98429726 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.13167804 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.18454527 |
| 4 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.83167408 |
| 5 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.29545923 |
| 6 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.06692259 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.39836783 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.01071737 |
| 9 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.96217341 |
| 10 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 3.80989288 |
| 11 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 3.80989288 |
| 12 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 3.80989288 |
| 13 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.61003379 |
| 14 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.26016080 |
| 15 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.05597035 |
| 16 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 3.03588463 |
| 17 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.96461867 |
| 18 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.69984362 |
| 19 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.58671601 |
| 20 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.56914972 |
| 21 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 2.51737425 |
| 22 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.48972656 |
| 23 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.47472996 |
| 24 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.45924858 |
| 25 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.40247989 |
| 26 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.26605341 |
| 27 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.15951350 |
| 28 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.15475960 |
| 29 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 2.07839116 |
| 30 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.88149020 |
| 31 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.87354491 |
| 32 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.86118166 |
| 33 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.85218566 |
| 34 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.80675062 |
| 35 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.80500879 |
| 36 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.77834478 |
| 37 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.76055386 |
| 38 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.75151709 |
| 39 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.74904969 |
| 40 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.74833890 |
| 41 | GATA1_22025678_ChIP-Seq_K562_Human | 1.74128185 |
| 42 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.71452540 |
| 43 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.64629487 |
| 44 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.61936374 |
| 45 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.61012712 |
| 46 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.57148638 |
| 47 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.57064125 |
| 48 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.55940491 |
| 49 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.49710259 |
| 50 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.47564943 |
| 51 | * NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.46537069 |
| 52 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.45762386 |
| 53 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.42003991 |
| 54 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.39337634 |
| 55 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.37988213 |
| 56 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.36179642 |
| 57 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.33363569 |
| 58 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.32706301 |
| 59 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.32519877 |
| 60 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.31955794 |
| 61 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.31404499 |
| 62 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.31128410 |
| 63 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.30771734 |
| 64 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.29604973 |
| 65 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.29565999 |
| 66 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.28670757 |
| 67 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.28230326 |
| 68 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.26312255 |
| 69 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.24102503 |
| 70 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.23612460 |
| 71 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.23607919 |
| 72 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.22835207 |
| 73 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22468821 |
| 74 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.21223759 |
| 75 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.19847986 |
| 76 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.19647663 |
| 77 | * NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.18962159 |
| 78 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.18421332 |
| 79 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.18024478 |
| 80 | KAP1_27257070_Chip-Seq_ESCs_Mouse | 1.16346174 |
| 81 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.15204193 |
| 82 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.15019740 |
| 83 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.14996205 |
| 84 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.14361985 |
| 85 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12826774 |
| 86 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.12650117 |
| 87 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.12607231 |
| 88 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.11685928 |
| 89 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.11216053 |
| 90 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.10509328 |
| 91 | * SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.09738030 |
| 92 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.09488273 |
| 93 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.08548999 |
| 94 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.07618097 |
| 95 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.06149105 |
| 96 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.05940996 |
| 97 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.04954391 |
| 98 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.02837435 |
| 99 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.02171504 |
| 100 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.01296055 |
| 101 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.01208314 |
| 102 | * NANOG_18692474_ChIP-Seq_MESCs_Mouse | 0.99805353 |
| 103 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.99740343 |
| 104 | * POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 0.98843024 |
| 105 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.98411592 |
| 106 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.98410643 |
| 107 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.98363952 |
| 108 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98099035 |
| 109 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.96979922 |
| 110 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.95306687 |
| 111 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.94729648 |
| 112 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.94388889 |
| 113 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93931290 |
| 114 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.93348628 |
| 115 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.92420545 |
| 116 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.92358703 |
| 117 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.91147173 |
| 118 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.91055043 |
| 119 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.90679284 |
| 120 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.87292901 |
| 121 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.86754232 |
| 122 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.86256794 |
| 123 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.84859609 |
| 124 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.83422981 |
| 125 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.82889173 |
| 126 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.82889173 |
| 127 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.82779852 |
| 128 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.81629759 |
| 129 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.81629759 |
| 130 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.77022210 |
| 131 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.76907051 |
| 132 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.76167651 |
| 133 | RXR_22108803_ChIP-Seq_LS180_Human | 0.75993289 |
| 134 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.75748026 |
| 135 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.75407701 |
| 136 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.75371412 |
| 137 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.73287620 |
| 138 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.72347951 |
| 139 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.72069274 |
| 140 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.71629171 |
| 141 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.71424086 |
| 142 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.70851815 |
| 143 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.70291703 |
| 144 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.70227514 |
| 145 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.70085016 |
| 146 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.69425447 |
| 147 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.69247991 |
| 148 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.68830980 |
| 149 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.66993698 |
| 150 | CJUN_26792858_Chip-Seq_BT549_Human | 0.66923232 |
| 151 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.65437620 |
| 152 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.64595347 |
| 153 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.63455843 |
| 154 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.62754207 |
| 155 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.62220539 |
| 156 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61317172 |
| 157 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.61075480 |
| 158 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.60573904 |
| 159 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.60535494 |
| 160 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.60305566 |
| 161 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.59815095 |
| 162 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.59175030 |
| 163 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.55230641 |
| 164 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.53969839 |
| 165 | CBP_21632823_ChIP-Seq_H3396_Human | 0.52942374 |
| 166 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.52011408 |
| 167 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.51411826 |
| 168 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.51179325 |
| 169 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.51015553 |
| 170 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.50947998 |
| 171 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.50850857 |
| 172 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.50786186 |
| 173 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.50403190 |
| 174 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.50201777 |
| 175 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.50041436 |
| 176 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.48658344 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.24490923 |
| 2 | MP0005360_urolithiasis | 5.87818527 |
| 3 | MP0005670_abnormal_white_adipose | 5.13580384 |
| 4 | MP0005365_abnormal_bile_salt | 5.03455054 |
| 5 | MP0003941_abnormal_skin_development | 4.47748711 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 4.25698586 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.77832999 |
| 8 | MP0005666_abnormal_adipose_tissue | 3.39571471 |
| 9 | MP0008875_abnormal_xenobiotic_pharmacok | 3.33088312 |
| 10 | MP0004130_abnormal_muscle_cell | 3.06795170 |
| 11 | MP0003252_abnormal_bile_duct | 2.90419056 |
| 12 | MP0005332_abnormal_amino_acid | 2.86830956 |
| 13 | MP0003693_abnormal_embryo_hatching | 2.81717731 |
| 14 | MP0004133_heterotaxia | 2.70537197 |
| 15 | MP0002876_abnormal_thyroid_physiology | 2.61977771 |
| 16 | MP0002118_abnormal_lipid_homeostasis | 2.53959900 |
| 17 | MP0003718_maternal_effect | 2.48339728 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 2.46901868 |
| 19 | MP0004957_abnormal_blastocyst_morpholog | 2.43883113 |
| 20 | MP0004019_abnormal_vitamin_homeostasis | 2.38795718 |
| 21 | MP0004185_abnormal_adipocyte_glucose | 2.38311284 |
| 22 | MP0005375_adipose_tissue_phenotype | 2.28078698 |
| 23 | MP0002971_abnormal_brown_adipose | 2.21398498 |
| 24 | MP0003195_calcinosis | 2.15702137 |
| 25 | MP0003890_abnormal_embryonic-extraembry | 2.11939419 |
| 26 | MP0010030_abnormal_orbit_morphology | 2.10883966 |
| 27 | MP0000609_abnormal_liver_physiology | 2.10464249 |
| 28 | MP0005377_hearing/vestibular/ear_phenot | 2.10009894 |
| 29 | MP0003878_abnormal_ear_physiology | 2.10009894 |
| 30 | MP0000537_abnormal_urethra_morphology | 2.08566918 |
| 31 | MP0003806_abnormal_nucleotide_metabolis | 2.05526896 |
| 32 | MP0001666_abnormal_nutrient_absorption | 1.97562483 |
| 33 | MP0002254_reproductive_system_inflammat | 1.94967565 |
| 34 | MP0003111_abnormal_nucleus_morphology | 1.81681074 |
| 35 | MP0005334_abnormal_fat_pad | 1.80981980 |
| 36 | MP0009643_abnormal_urine_homeostasis | 1.75285307 |
| 37 | MP0005319_abnormal_enzyme/_coenzyme | 1.71615297 |
| 38 | MP0009115_abnormal_fat_cell | 1.70677317 |
| 39 | MP0005535_abnormal_body_temperature | 1.65708796 |
| 40 | MP0002138_abnormal_hepatobiliary_system | 1.64353385 |
| 41 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.60208488 |
| 42 | MP0001293_anophthalmia | 1.58476997 |
| 43 | MP0001661_extended_life_span | 1.57762873 |
| 44 | MP0003186_abnormal_redox_activity | 1.55702865 |
| 45 | MP0002837_dystrophic_cardiac_calcinosis | 1.53824080 |
| 46 | MP0003136_yellow_coat_color | 1.52975809 |
| 47 | MP0001730_embryonic_growth_arrest | 1.50370194 |
| 48 | MP0001764_abnormal_homeostasis | 1.49749434 |
| 49 | MP0005647_abnormal_sex_gland | 1.46662919 |
| 50 | MP0010352_gastrointestinal_tract_polyps | 1.46524288 |
| 51 | MP0008932_abnormal_embryonic_tissue | 1.43648604 |
| 52 | MP0005083_abnormal_biliary_tract | 1.43065435 |
| 53 | MP0003119_abnormal_digestive_system | 1.40178515 |
| 54 | MP0002697_abnormal_eye_size | 1.40090611 |
| 55 | MP0008438_abnormal_cutaneous_collagen | 1.39153330 |
| 56 | MP0009840_abnormal_foam_cell | 1.38931937 |
| 57 | MP0000003_abnormal_adipose_tissue | 1.36164050 |
| 58 | MP0003705_abnormal_hypodermis_morpholog | 1.35787520 |
| 59 | MP0001756_abnormal_urination | 1.35374575 |
| 60 | MP0003077_abnormal_cell_cycle | 1.35306262 |
| 61 | MP0005367_renal/urinary_system_phenotyp | 1.34380798 |
| 62 | MP0000516_abnormal_urinary_system | 1.34380798 |
| 63 | MP0010094_abnormal_chromosome_stability | 1.31085067 |
| 64 | MP0002970_abnormal_white_adipose | 1.30485924 |
| 65 | MP0003937_abnormal_limbs/digits/tail_de | 1.29746567 |
| 66 | MP0003690_abnormal_glial_cell | 1.28296868 |
| 67 | MP0002085_abnormal_embryonic_tissue | 1.27523830 |
| 68 | MP0000013_abnormal_adipose_tissue | 1.26658187 |
| 69 | MP0002084_abnormal_developmental_patter | 1.23768152 |
| 70 | MP0009703_decreased_birth_body | 1.22998558 |
| 71 | MP0002089_abnormal_postnatal_growth/wei | 1.22757080 |
| 72 | MP0001346_abnormal_lacrimal_gland | 1.21872219 |
| 73 | MP0002078_abnormal_glucose_homeostasis | 1.21743231 |
| 74 | MP0005501_abnormal_skin_physiology | 1.20958691 |
| 75 | MP0006292_abnormal_olfactory_placode | 1.20660353 |
| 76 | MP0001881_abnormal_mammary_gland | 1.17530705 |
| 77 | MP0001849_ear_inflammation | 1.14542518 |
| 78 | MP0008057_abnormal_DNA_replication | 1.11447965 |
| 79 | MP0005380_embryogenesis_phenotype | 1.10585386 |
| 80 | MP0001672_abnormal_embryogenesis/_devel | 1.10585386 |
| 81 | MP0010386_abnormal_urinary_bladder | 1.10462045 |
| 82 | MP0005448_abnormal_energy_balance | 1.10091200 |
| 83 | MP0002111_abnormal_tail_morphology | 1.09755695 |
| 84 | MP0003959_abnormal_lean_body | 1.08892840 |
| 85 | MP0010234_abnormal_vibrissa_follicle | 1.08019026 |
| 86 | MP0002653_abnormal_ependyma_morphology | 1.07423223 |
| 87 | MP0005275_abnormal_skin_tensile | 1.06998624 |
| 88 | MP0004043_abnormal_pH_regulation | 1.06359907 |
| 89 | MP0001286_abnormal_eye_development | 1.06102834 |
| 90 | MP0009379_abnormal_foot_pigmentation | 1.04931004 |
| 91 | MP0008789_abnormal_olfactory_epithelium | 1.03513510 |
| 92 | MP0002132_abnormal_respiratory_system | 1.03307270 |
| 93 | MP0006036_abnormal_mitochondrial_physio | 1.02538944 |
| 94 | MP0005636_abnormal_mineral_homeostasis | 1.01841800 |
| 95 | MP0000579_abnormal_nail_morphology | 1.00776325 |
| 96 | MP0008877_abnormal_DNA_methylation | 0.99864973 |
| 97 | MP0009053_abnormal_anal_canal | 0.98810812 |
| 98 | MP0003566_abnormal_cell_adhesion | 0.98648589 |
| 99 | MP0000350_abnormal_cell_proliferation | 0.98584284 |
| 100 | MP0008058_abnormal_DNA_repair | 0.97482820 |
| 101 | MP0003868_abnormal_feces_composition | 0.96894922 |
| 102 | MP0002233_abnormal_nose_morphology | 0.95172166 |
| 103 | MP0003984_embryonic_growth_retardation | 0.95116854 |
| 104 | MP0000762_abnormal_tongue_morphology | 0.93866800 |
| 105 | MP0002136_abnormal_kidney_physiology | 0.93785698 |
| 106 | MP0002080_prenatal_lethality | 0.93713078 |
| 107 | MP0009764_decreased_sensitivity_to | 0.93364145 |
| 108 | MP0002088_abnormal_embryonic_growth/wei | 0.92537327 |
| 109 | MP0001697_abnormal_embryo_size | 0.91073109 |
| 110 | MP0000049_abnormal_middle_ear | 0.88052842 |
| 111 | MP0000598_abnormal_liver_morphology | 0.87974704 |
| 112 | MP0002796_impaired_skin_barrier | 0.86191525 |
| 113 | MP0003011_delayed_dark_adaptation | 0.85673746 |
| 114 | MP0009780_abnormal_chondrocyte_physiolo | 0.85447450 |
| 115 | MP0002168_other_aberrant_phenotype | 0.83534117 |
| 116 | MP0005452_abnormal_adipose_tissue | 0.83489552 |
| 117 | MP0000534_abnormal_ureter_morphology | 0.83124883 |
| 118 | MP0005451_abnormal_body_composition | 0.82371892 |
| 119 | MP0004197_abnormal_fetal_growth/weight/ | 0.82258771 |
| 120 | MP0003724_increased_susceptibility_to | 0.80832024 |
| 121 | MP0003953_abnormal_hormone_level | 0.80137311 |
| 122 | MP0009763_increased_sensitivity_to | 0.79159883 |
| 123 | MP0008007_abnormal_cellular_replicative | 0.78001070 |
| 124 | MP0009642_abnormal_blood_homeostasis | 0.77757467 |
| 125 | MP0005076_abnormal_cell_differentiation | 0.76826132 |
| 126 | MP0001485_abnormal_pinna_reflex | 0.76196649 |
| 127 | MP0001765_abnormal_ion_homeostasis | 0.75017323 |
| 128 | MP0003938_abnormal_ear_development | 0.73942383 |
| 129 | MP0000432_abnormal_head_morphology | 0.73627230 |
| 130 | MP0002086_abnormal_extraembryonic_tissu | 0.72158310 |
| 131 | MP0008961_abnormal_basal_metabolism | 0.71656168 |
| 132 | MP0002277_abnormal_respiratory_mucosa | 0.70542008 |
| 133 | MP0000428_abnormal_craniofacial_morphol | 0.70414091 |
| 134 | MP0000678_abnormal_parathyroid_gland | 0.70019901 |
| 135 | MP0002092_abnormal_eye_morphology | 0.69522848 |
| 136 | MP0003567_abnormal_fetal_cardiomyocyte | 0.68933938 |
| 137 | MP0002060_abnormal_skin_morphology | 0.68622857 |
| 138 | MP0005084_abnormal_gallbladder_morpholo | 0.67766671 |
| 139 | MP0000627_abnormal_mammary_gland | 0.67617317 |
| 140 | MP0000230_abnormal_systemic_arterial | 0.65823123 |
| 141 | MP0004782_abnormal_surfactant_physiolog | 0.65075155 |
| 142 | MP0004264_abnormal_extraembryonic_tissu | 0.62510671 |
| 143 | MP0000604_amyloidosis | 0.62452407 |
| 144 | MP0000538_abnormal_urinary_bladder | 0.62273657 |
| 145 | MP0005220_abnormal_exocrine_pancreas | 0.59978745 |
| 146 | MP0004272_abnormal_basement_membrane | 0.59638215 |
| 147 | MP0004147_increased_porphyrin_level | 0.57007723 |
| 148 | MP0005376_homeostasis/metabolism_phenot | 0.56806073 |
| 149 | MP0008469_abnormal_protein_level | 0.56083576 |
| 150 | MP0009697_abnormal_copulation | 0.54934976 |
| 151 | MP0009765_abnormal_xenobiotic_induced | 0.54251989 |
| 152 | MP0002166_altered_tumor_susceptibility | 0.54094810 |
| 153 | MP0006138_congestive_heart_failure | 0.52776958 |
| 154 | MP0005167_abnormal_blood-brain_barrier | 0.51053181 |
| 155 | MP0000427_abnormal_hair_cycle | 0.50726253 |
| 156 | MP0001177_atelectasis | 0.49865788 |
| 157 | MP0003045_fibrosis | 0.47724984 |
| 158 | MP0002928_abnormal_bile_duct | 0.47000998 |
| 159 | MP0003656_abnormal_erythrocyte_physiolo | 0.46991411 |
| 160 | MP0009672_abnormal_birth_weight | 0.46861947 |
| 161 | MP0008872_abnormal_physiological_respon | 0.46505299 |
| 162 | MP0005395_other_phenotype | 0.46166373 |
| 163 | MP0001501_abnormal_sleep_pattern | 0.43546705 |
| 164 | MP0000566_synostosis | 0.43409024 |
| 165 | MP0002069_abnormal_eating/drinking_beha | 0.42882730 |
| 166 | MP0002909_abnormal_adrenal_gland | 0.42799992 |
| 167 | MP0005058_abnormal_lysosome_morphology | 0.42014845 |
| 168 | MP0005266_abnormal_metabolism | 0.40410545 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperglycinuria (HP:0003108) | 6.91346855 |
| 2 | Chronic bronchitis (HP:0004469) | 6.43901226 |
| 3 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 6.03373010 |
| 4 | Abnormality of serine family amino acid metabolism (HP:0010894) | 5.97025236 |
| 5 | Abnormality of glycine metabolism (HP:0010895) | 5.97025236 |
| 6 | Hyperglycinemia (HP:0002154) | 5.33507194 |
| 7 | Abnormal respiratory motile cilium physiology (HP:0012261) | 5.13757858 |
| 8 | Abnormal respiratory epithelium morphology (HP:0012253) | 5.11208590 |
| 9 | Abnormal respiratory motile cilium morphology (HP:0005938) | 5.11208590 |
| 10 | Rhinitis (HP:0012384) | 5.04138757 |
| 11 | Complement deficiency (HP:0004431) | 4.98379253 |
| 12 | Abnormal ciliary motility (HP:0012262) | 4.84210966 |
| 13 | Intrahepatic cholestasis (HP:0001406) | 4.76077371 |
| 14 | Hyperammonemia (HP:0001987) | 4.69424090 |
| 15 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.67715819 |
| 16 | Xanthomatosis (HP:0000991) | 4.66186185 |
| 17 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 4.64436474 |
| 18 | Absent/shortened dynein arms (HP:0200106) | 4.64436474 |
| 19 | Ketosis (HP:0001946) | 4.62582885 |
| 20 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.49463563 |
| 21 | Hypoglycemic coma (HP:0001325) | 4.44408254 |
| 22 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.42631634 |
| 23 | Deep venous thrombosis (HP:0002625) | 4.40946536 |
| 24 | Hyperlipoproteinemia (HP:0010980) | 4.15551417 |
| 25 | Ketoacidosis (HP:0001993) | 4.10270616 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 3.92496516 |
| 27 | Hydroxyprolinuria (HP:0003080) | 3.87127547 |
| 28 | Abnormality of proline metabolism (HP:0010907) | 3.87127547 |
| 29 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.86232750 |
| 30 | Oligomenorrhea (HP:0000876) | 3.82800737 |
| 31 | Epidermoid cyst (HP:0200040) | 3.79688302 |
| 32 | Dicarboxylic aciduria (HP:0003215) | 3.73593359 |
| 33 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.73593359 |
| 34 | Bronchiectasis (HP:0002110) | 3.67104607 |
| 35 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.66302604 |
| 36 | Prolonged partial thromboplastin time (HP:0003645) | 3.60702429 |
| 37 | Abnormality of purine metabolism (HP:0004352) | 3.56307828 |
| 38 | Hypertriglyceridemia (HP:0002155) | 3.44054792 |
| 39 | Abnormality of complement system (HP:0005339) | 3.39250238 |
| 40 | Hypolipoproteinemia (HP:0010981) | 3.35650968 |
| 41 | Gout (HP:0001997) | 3.33492300 |
| 42 | Acanthosis nigricans (HP:0000956) | 3.31459436 |
| 43 | Generalized aminoaciduria (HP:0002909) | 3.31280567 |
| 44 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.30243886 |
| 45 | Abnormality of serum amino acid levels (HP:0003112) | 3.24081587 |
| 46 | Proximal tubulopathy (HP:0000114) | 3.18062756 |
| 47 | Septo-optic dysplasia (HP:0100842) | 3.15222443 |
| 48 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.10775331 |
| 49 | Hypobetalipoproteinemia (HP:0003563) | 3.05511168 |
| 50 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.04713916 |
| 51 | Abnormality of nucleobase metabolism (HP:0010932) | 3.02523179 |
| 52 | Myocardial infarction (HP:0001658) | 2.98443415 |
| 53 | Renal salt wasting (HP:0000127) | 2.97941641 |
| 54 | Increased purine levels (HP:0004368) | 2.97047344 |
| 55 | Hyperuricemia (HP:0002149) | 2.97047344 |
| 56 | Joint hemorrhage (HP:0005261) | 2.88625869 |
| 57 | Choanal stenosis (HP:0000452) | 2.85753523 |
| 58 | Metabolic acidosis (HP:0001942) | 2.81433506 |
| 59 | Lethargy (HP:0001254) | 2.73381161 |
| 60 | Fat malabsorption (HP:0002630) | 2.71956030 |
| 61 | Hemorrhage of the eye (HP:0011885) | 2.71904332 |
| 62 | Hypercholesterolemia (HP:0003124) | 2.69522859 |
| 63 | Renal cortical cysts (HP:0000803) | 2.68676545 |
| 64 | Abnormality of the common coagulation pathway (HP:0010990) | 2.67746453 |
| 65 | Delayed CNS myelination (HP:0002188) | 2.67294069 |
| 66 | Pancreatitis (HP:0001733) | 2.66493850 |
| 67 | Partial duplication of thumb phalanx (HP:0009944) | 2.61596150 |
| 68 | Abnormality of the intrinsic pathway (HP:0010989) | 2.55727735 |
| 69 | Myoglobinuria (HP:0002913) | 2.54333157 |
| 70 | Maternal diabetes (HP:0009800) | 2.54196399 |
| 71 | Bifid scrotum (HP:0000048) | 2.51070430 |
| 72 | Rickets (HP:0002748) | 2.48228545 |
| 73 | Abnormality of chloride homeostasis (HP:0011422) | 2.46979212 |
| 74 | Nausea (HP:0002018) | 2.46943439 |
| 75 | Abnormality of the labia minora (HP:0012880) | 2.46442816 |
| 76 | Sensorimotor neuropathy (HP:0007141) | 2.45343125 |
| 77 | Pigmentary retinal degeneration (HP:0001146) | 2.45157694 |
| 78 | Systemic lupus erythematosus (HP:0002725) | 2.42685271 |
| 79 | Vomiting (HP:0002013) | 2.39326635 |
| 80 | Conjugated hyperbilirubinemia (HP:0002908) | 2.38125193 |
| 81 | Colon cancer (HP:0003003) | 2.37608700 |
| 82 | Abnormality of the salivary glands (HP:0010286) | 2.36885342 |
| 83 | Infertility (HP:0000789) | 2.36881931 |
| 84 | Vascular calcification (HP:0004934) | 2.32281266 |
| 85 | Multiple enchondromatosis (HP:0005701) | 2.32053188 |
| 86 | Abnormality of the lacrimal duct (HP:0011481) | 2.31428019 |
| 87 | Facial cleft (HP:0002006) | 2.31188053 |
| 88 | Abnormality of methionine metabolism (HP:0010901) | 2.28975265 |
| 89 | Skin nodule (HP:0200036) | 2.28376195 |
| 90 | Bronchitis (HP:0012387) | 2.27933726 |
| 91 | Hyperaldosteronism (HP:0000859) | 2.27575805 |
| 92 | Hypoglycemic seizures (HP:0002173) | 2.25981890 |
| 93 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.21653254 |
| 94 | Spastic diplegia (HP:0001264) | 2.20933509 |
| 95 | Enlarged kidneys (HP:0000105) | 2.20462973 |
| 96 | Cardiovascular calcification (HP:0011915) | 2.19919620 |
| 97 | Aplasia involving bones of the extremities (HP:0009825) | 2.18405622 |
| 98 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.18405622 |
| 99 | Aplasia of the phalanges of the hand (HP:0009802) | 2.18405622 |
| 100 | Selective tooth agenesis (HP:0001592) | 2.17445491 |
| 101 | Stenosis of the external auditory canal (HP:0000402) | 2.16761725 |
| 102 | Megaloblastic anemia (HP:0001889) | 2.16235135 |
| 103 | Hyperglycemia (HP:0003074) | 2.14360430 |
| 104 | Hepatocellular carcinoma (HP:0001402) | 2.13285143 |
| 105 | Insulin resistance (HP:0000855) | 2.13085280 |
| 106 | Brushfield spots (HP:0001088) | 2.11494289 |
| 107 | Bronchomalacia (HP:0002780) | 2.10327657 |
| 108 | Nasal polyposis (HP:0100582) | 2.10251830 |
| 109 | Partial duplication of the phalanx of hand (HP:0009999) | 2.09593189 |
| 110 | Steatorrhea (HP:0002570) | 2.09557429 |
| 111 | Methylmalonic aciduria (HP:0012120) | 2.07221077 |
| 112 | Hyperbilirubinemia (HP:0002904) | 2.02305660 |
| 113 | Osteomalacia (HP:0002749) | 2.00255690 |
| 114 | Hepatoblastoma (HP:0002884) | 1.99918205 |
| 115 | Limb hypertonia (HP:0002509) | 1.99391994 |
| 116 | Alkalosis (HP:0001948) | 1.98942071 |
| 117 | Absent septum pellucidum (HP:0001331) | 1.98562458 |
| 118 | Esophageal varix (HP:0002040) | 1.97618470 |
| 119 | Long foot (HP:0001833) | 1.97350375 |
| 120 | Abnormality of the dental root (HP:0006486) | 1.95016222 |
| 121 | Taurodontia (HP:0000679) | 1.95016222 |
| 122 | Abnormality of permanent molar morphology (HP:0011071) | 1.95016222 |
| 123 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.94953883 |
| 124 | Increased muscle lipid content (HP:0009058) | 1.94686608 |
| 125 | Rhabdomyolysis (HP:0003201) | 1.93392162 |
| 126 | Median cleft lip (HP:0000161) | 1.92797163 |
| 127 | Irritability (HP:0000737) | 1.92672573 |
| 128 | Cerebral edema (HP:0002181) | 1.92388969 |
| 129 | Hyperactive renin-angiotensin system (HP:0000841) | 1.91564337 |
| 130 | Subcapsular cataract (HP:0000523) | 1.90889546 |
| 131 | Broad metatarsal (HP:0001783) | 1.90819124 |
| 132 | Abnormality of urine glucose concentration (HP:0011016) | 1.90448627 |
| 133 | Glycosuria (HP:0003076) | 1.90448627 |
| 134 | Abnormal cartilage morphology (HP:0002763) | 1.90212750 |
| 135 | Right ventricular cardiomyopathy (HP:0011663) | 1.89557696 |
| 136 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.89140044 |
| 137 | Tachypnea (HP:0002789) | 1.88900785 |
| 138 | Abnormality of renin-angiotensin system (HP:0000847) | 1.88681660 |
| 139 | Elevated hepatic transaminases (HP:0002910) | 1.88296055 |
| 140 | Abnormality of the nasolacrimal system (HP:0000614) | 1.87951508 |
| 141 | Male infertility (HP:0003251) | 1.87173285 |
| 142 | Increased circulating renin level (HP:0000848) | 1.86527972 |
| 143 | Hypokalemic alkalosis (HP:0001949) | 1.85549764 |
| 144 | Neonatal hypoglycemia (HP:0001998) | 1.85008188 |
| 145 | Nasolacrimal duct obstruction (HP:0000579) | 1.83377513 |
| 146 | Abnormality of the septum pellucidum (HP:0007375) | 1.82383253 |
| 147 | Neonatal onset (HP:0003623) | 1.82223545 |
| 148 | Abnormality of the renal cortex (HP:0011035) | 1.80634150 |
| 149 | Abnormality of sodium homeostasis (HP:0010931) | 1.79610562 |
| 150 | Abnormality of the dental pulp (HP:0006479) | 1.78996472 |
| 151 | Nephrolithiasis (HP:0000787) | 1.78623494 |
| 152 | Thyroid-stimulating hormone excess (HP:0002925) | 1.78459828 |
| 153 | Breast aplasia (HP:0100783) | 1.77903104 |
| 154 | Impulsivity (HP:0100710) | 1.75627060 |
| 155 | Abnormality of vitamin metabolism (HP:0100508) | 1.74587437 |
| 156 | Vaginal fistula (HP:0004320) | 1.73664139 |
| 157 | Bilateral microphthalmos (HP:0007633) | 1.73113122 |
| 158 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.72829716 |
| 159 | Abnormality of homocysteine metabolism (HP:0010919) | 1.72363610 |
| 160 | Homocystinuria (HP:0002156) | 1.72363610 |
| 161 | Abnormality of molar (HP:0011077) | 1.70466269 |
| 162 | Abnormality of molar morphology (HP:0011070) | 1.70466269 |
| 163 | Humeroradial synostosis (HP:0003041) | 1.70134677 |
| 164 | Synostosis involving the elbow (HP:0003938) | 1.70134677 |
| 165 | Hypomagnesemia (HP:0002917) | 1.69591746 |
| 166 | Hyperphosphaturia (HP:0003109) | 1.67363578 |
| 167 | Hyponatremia (HP:0002902) | 1.66728138 |
| 168 | Carpal bone hypoplasia (HP:0001498) | 1.66127596 |
| 169 | Reduced antithrombin III activity (HP:0001976) | 1.64373620 |
| 170 | Supernumerary spleens (HP:0009799) | 1.63285770 |
| 171 | Turricephaly (HP:0000262) | 1.61457311 |
| 172 | Aplasia/Hypoplasia of the breasts (HP:0010311) | 1.61158240 |
| 173 | Esophageal atresia (HP:0002032) | 1.60384705 |
| 174 | Abnormal lung lobation (HP:0002101) | 1.60128437 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.51802261 |
| 2 | SIK1 | 5.20428029 |
| 3 | CAMK1D | 4.47513165 |
| 4 | TTK | 3.53921726 |
| 5 | CAMK1G | 3.32408435 |
| 6 | TRIB3 | 3.30410435 |
| 7 | CDC7 | 3.27892753 |
| 8 | MST4 | 3.10836874 |
| 9 | VRK2 | 2.61505804 |
| 10 | LATS1 | 2.56660852 |
| 11 | ERN1 | 2.56547681 |
| 12 | INSRR | 2.54430051 |
| 13 | PDK3 | 2.52565466 |
| 14 | PDK4 | 2.52565466 |
| 15 | SMG1 | 2.50590169 |
| 16 | FRK | 2.48006978 |
| 17 | MAPK15 | 2.45351506 |
| 18 | NME1 | 2.41339365 |
| 19 | BRSK2 | 2.40566525 |
| 20 | MAP3K10 | 2.34138211 |
| 21 | FGFR4 | 2.28411967 |
| 22 | BUB1 | 2.25248925 |
| 23 | MST1R | 2.18311470 |
| 24 | TSSK6 | 2.10033007 |
| 25 | OXSR1 | 2.05518875 |
| 26 | MKNK2 | 2.00494825 |
| 27 | PBK | 1.91741224 |
| 28 | MKNK1 | 1.80773358 |
| 29 | PRKAA2 | 1.79806265 |
| 30 | PDK2 | 1.78748875 |
| 31 | TAF1 | 1.78091977 |
| 32 | STK38L | 1.74094998 |
| 33 | LMTK2 | 1.73290020 |
| 34 | RIPK1 | 1.70783316 |
| 35 | STK39 | 1.68413431 |
| 36 | FGFR2 | 1.64610696 |
| 37 | WNK4 | 1.63927771 |
| 38 | SRPK1 | 1.61962101 |
| 39 | PLK3 | 1.59994607 |
| 40 | WNK3 | 1.56196113 |
| 41 | PAK4 | 1.54760856 |
| 42 | WEE1 | 1.48076408 |
| 43 | MAP3K9 | 1.46115168 |
| 44 | TIE1 | 1.44383172 |
| 45 | STK24 | 1.42043871 |
| 46 | PLK1 | 1.36035249 |
| 47 | TNIK | 1.31913514 |
| 48 | FGFR3 | 1.23850590 |
| 49 | NEK1 | 1.23819032 |
| 50 | IRAK3 | 1.22257298 |
| 51 | AKT3 | 1.21261552 |
| 52 | STK16 | 1.17623893 |
| 53 | CDK12 | 1.16462815 |
| 54 | PRKAA1 | 1.10163815 |
| 55 | ALK | 1.09009352 |
| 56 | ZAK | 1.07771868 |
| 57 | EEF2K | 1.07016933 |
| 58 | PINK1 | 1.06627911 |
| 59 | DYRK2 | 1.06244195 |
| 60 | SGK3 | 1.05169968 |
| 61 | EIF2AK1 | 1.05087779 |
| 62 | FER | 1.04951227 |
| 63 | CHEK2 | 1.04802579 |
| 64 | TAOK3 | 1.04329013 |
| 65 | NEK9 | 1.03573862 |
| 66 | MAPK11 | 1.03225246 |
| 67 | SGK2 | 1.00786989 |
| 68 | RPS6KB2 | 0.99826255 |
| 69 | JAK1 | 0.99326361 |
| 70 | ERBB4 | 0.98422579 |
| 71 | STK38 | 0.98069600 |
| 72 | CDK6 | 0.95348692 |
| 73 | SGK494 | 0.91017466 |
| 74 | SGK223 | 0.91017466 |
| 75 | DAPK2 | 0.89555462 |
| 76 | VRK1 | 0.86909148 |
| 77 | PIK3CA | 0.86838625 |
| 78 | TGFBR2 | 0.86561233 |
| 79 | DYRK3 | 0.85889176 |
| 80 | PLK4 | 0.84875646 |
| 81 | BRSK1 | 0.84763734 |
| 82 | MAP3K7 | 0.82851822 |
| 83 | MAP2K4 | 0.82791646 |
| 84 | JAK2 | 0.81037764 |
| 85 | PTK6 | 0.81014019 |
| 86 | EIF2AK3 | 0.80550225 |
| 87 | CDK19 | 0.79570997 |
| 88 | NTRK1 | 0.78540117 |
| 89 | AURKB | 0.77145523 |
| 90 | PIK3CG | 0.75021703 |
| 91 | CDK7 | 0.73586543 |
| 92 | PDPK1 | 0.73188597 |
| 93 | PASK | 0.72149430 |
| 94 | NEK2 | 0.69825127 |
| 95 | CDK9 | 0.69623191 |
| 96 | NLK | 0.69217568 |
| 97 | EPHA2 | 0.67169275 |
| 98 | MAP2K1 | 0.65135573 |
| 99 | GSK3A | 0.63278929 |
| 100 | ATR | 0.63045967 |
| 101 | PRKACG | 0.61975327 |
| 102 | MELK | 0.59524360 |
| 103 | EPHB2 | 0.59255976 |
| 104 | CHEK1 | 0.58887155 |
| 105 | LATS2 | 0.57800680 |
| 106 | MTOR | 0.57641753 |
| 107 | PDGFRA | 0.56245874 |
| 108 | PRKCZ | 0.54512368 |
| 109 | NME2 | 0.54342788 |
| 110 | PHKG2 | 0.54309005 |
| 111 | PHKG1 | 0.54309005 |
| 112 | MET | 0.52921319 |
| 113 | CSNK1E | 0.51971263 |
| 114 | AURKA | 0.51523145 |
| 115 | MAP3K8 | 0.51188116 |
| 116 | IGF1R | 0.50238071 |
| 117 | PDK1 | 0.49503423 |
| 118 | EIF2AK2 | 0.49346404 |
| 119 | ATM | 0.49280159 |
| 120 | STK3 | 0.49218128 |
| 121 | MYLK | 0.49129861 |
| 122 | TNK2 | 0.48685077 |
| 123 | PKN2 | 0.48369950 |
| 124 | GRK1 | 0.48293059 |
| 125 | PRKG2 | 0.47002558 |
| 126 | NUAK1 | 0.46665790 |
| 127 | ERBB2 | 0.46308592 |
| 128 | TYK2 | 0.45710133 |
| 129 | MAP3K14 | 0.45235798 |
| 130 | EPHA3 | 0.44339756 |
| 131 | MATK | 0.44243494 |
| 132 | STK4 | 0.42917749 |
| 133 | MAP3K6 | 0.41116928 |
| 134 | PRKCH | 0.40618561 |
| 135 | PRKCI | 0.39753834 |
| 136 | ACVR1B | 0.39282928 |
| 137 | MAPK12 | 0.39226836 |
| 138 | PRKDC | 0.39116016 |
| 139 | CDK1 | 0.37743742 |
| 140 | CDK2 | 0.36004779 |
| 141 | BCR | 0.35744932 |
| 142 | MAP3K3 | 0.35436186 |
| 143 | PTK2 | 0.35125287 |
| 144 | CAMK1 | 0.33500510 |
| 145 | SGK1 | 0.32012446 |
| 146 | CSNK1G1 | 0.31510726 |
| 147 | ABL2 | 0.31508329 |
| 148 | EPHB1 | 0.30465107 |
| 149 | CSNK2A2 | 0.30071151 |
| 150 | IRAK1 | 0.30027284 |
| 151 | CSNK2A1 | 0.29628117 |
| 152 | FGFR1 | 0.29482945 |
| 153 | PRKD3 | 0.29233415 |
| 154 | BMX | 0.28170937 |
| 155 | NEK6 | 0.27461992 |
| 156 | DAPK1 | 0.27260599 |
| 157 | DMPK | 0.26722787 |
| 158 | CSNK1A1 | 0.26480260 |
| 159 | ICK | 0.26377768 |
| 160 | EGFR | 0.25097738 |
| 161 | CDK4 | 0.24785893 |
| 162 | RPS6KB1 | 0.23866646 |
| 163 | DDR2 | 0.23332173 |
| 164 | FLT3 | 0.23228520 |
| 165 | MAP3K2 | 0.23185281 |
| 166 | RET | 0.23079759 |
| 167 | PRKD1 | 0.22421315 |
| 168 | STK11 | 0.22344774 |
| 169 | BRD4 | 0.22120198 |
| 170 | INSR | 0.21410883 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.62323967 |
| 2 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.38299276 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.26894256 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.17413354 |
| 5 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.98927834 |
| 6 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.94299014 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.86233394 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.82238440 |
| 9 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.46507547 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.41832931 |
| 11 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.41319792 |
| 12 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.39227071 |
| 13 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.26375842 |
| 14 | Peroxisome_Homo sapiens_hsa04146 | 2.20519852 |
| 15 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.17531010 |
| 16 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.15121065 |
| 17 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.14009186 |
| 18 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.09480502 |
| 19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.07886339 |
| 20 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.99253715 |
| 21 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.90548182 |
| 22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.85650553 |
| 23 | Mismatch repair_Homo sapiens_hsa03430 | 1.83786283 |
| 24 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.82676966 |
| 25 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.81590137 |
| 26 | DNA replication_Homo sapiens_hsa03030 | 1.70397424 |
| 27 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.65906757 |
| 28 | Carbon metabolism_Homo sapiens_hsa01200 | 1.58581327 |
| 29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.56038867 |
| 30 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.53611787 |
| 31 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.52672683 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.44603953 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.39700991 |
| 34 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.38164396 |
| 35 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.35630475 |
| 36 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.33523946 |
| 37 | Histidine metabolism_Homo sapiens_hsa00340 | 1.31163952 |
| 38 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.31013240 |
| 39 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.30219454 |
| 40 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.30187453 |
| 41 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.28489585 |
| 42 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.25553109 |
| 43 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.24477635 |
| 44 | Bile secretion_Homo sapiens_hsa04976 | 1.21836702 |
| 45 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.21545314 |
| 46 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.21133220 |
| 47 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.21069983 |
| 48 | Proteasome_Homo sapiens_hsa03050 | 1.20049588 |
| 49 | Retinol metabolism_Homo sapiens_hsa00830 | 1.19859405 |
| 50 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.17513022 |
| 51 | Spliceosome_Homo sapiens_hsa03040 | 1.14889397 |
| 52 | ABC transporters_Homo sapiens_hsa02010 | 1.12952370 |
| 53 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.11519986 |
| 54 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.11502388 |
| 55 | Ribosome_Homo sapiens_hsa03010 | 1.03946572 |
| 56 | RNA polymerase_Homo sapiens_hsa03020 | 1.03678903 |
| 57 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.02569602 |
| 58 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.01472668 |
| 59 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.99943063 |
| 60 | Lysine degradation_Homo sapiens_hsa00310 | 0.97979853 |
| 61 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.96604387 |
| 62 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.96534325 |
| 63 | Base excision repair_Homo sapiens_hsa03410 | 0.95164584 |
| 64 | RNA transport_Homo sapiens_hsa03013 | 0.92881575 |
| 65 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.89715272 |
| 66 | Huntingtons disease_Homo sapiens_hsa05016 | 0.88335429 |
| 67 | Tight junction_Homo sapiens_hsa04530 | 0.86628168 |
| 68 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.81904952 |
| 69 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.79714298 |
| 70 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.77697440 |
| 71 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.77465749 |
| 72 | Cell cycle_Homo sapiens_hsa04110 | 0.77082046 |
| 73 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.72784600 |
| 74 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.72287352 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.71075459 |
| 76 | Adherens junction_Homo sapiens_hsa04520 | 0.70861532 |
| 77 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70330913 |
| 78 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.67524933 |
| 79 | Thyroid cancer_Homo sapiens_hsa05216 | 0.64566861 |
| 80 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.64285540 |
| 81 | Homologous recombination_Homo sapiens_hsa03440 | 0.63875741 |
| 82 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.62913113 |
| 83 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.61934740 |
| 84 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.61324129 |
| 85 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.57025006 |
| 86 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.55826162 |
| 87 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.54124249 |
| 88 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.53765214 |
| 89 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.51785533 |
| 90 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.50742234 |
| 91 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50325295 |
| 92 | RNA degradation_Homo sapiens_hsa03018 | 0.49175094 |
| 93 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.48621076 |
| 94 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.48004211 |
| 95 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.43791187 |
| 96 | Sulfur relay system_Homo sapiens_hsa04122 | 0.43395828 |
| 97 | Metabolic pathways_Homo sapiens_hsa01100 | 0.42884261 |
| 98 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.42772336 |
| 99 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.42699757 |
| 100 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.40001028 |
| 101 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.39749681 |
| 102 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.38994806 |
| 103 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.38794452 |
| 104 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.38633665 |
| 105 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.37845307 |
| 106 | Basal transcription factors_Homo sapiens_hsa03022 | 0.37594111 |
| 107 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.35634826 |
| 108 | Purine metabolism_Homo sapiens_hsa00230 | 0.34717197 |
| 109 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.33611732 |
| 110 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.33270767 |
| 111 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.29725864 |
| 112 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.27661395 |
| 113 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.24657250 |
| 114 | Galactose metabolism_Homo sapiens_hsa00052 | 0.13975604 |
| 115 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.13702907 |
| 116 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.13654790 |
| 117 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.07929332 |
| 118 | Prion diseases_Homo sapiens_hsa05020 | 0.07550256 |
| 119 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.07355884 |
| 120 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.05927077 |
| 121 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.05685224 |
| 122 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.02749248 |
| 123 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.02519693 |
| 124 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.00893557 |
| 125 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.00394887 |
| 126 | Renin secretion_Homo sapiens_hsa04924 | -0.0819495 |
| 127 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0787356 |
| 128 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0784962 |
| 129 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0734387 |
| 130 | Hepatitis C_Homo sapiens_hsa05160 | -0.0706229 |
| 131 | Lysosome_Homo sapiens_hsa04142 | -0.0597699 |
| 132 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0485159 |
| 133 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0312785 |
| 134 | Mineral absorption_Homo sapiens_hsa04978 | -0.0265510 |
| 135 | One carbon pool by folate_Homo sapiens_hsa00670 | -0.0220600 |
| 136 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0089558 |

